Sunflower Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 27.19% vs -56.30% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 96.94% vs -78.25% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "843.90",
          "val2": "663.50",
          "chgp": "27.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "133.20",
          "val2": "90.00",
          "chgp": "48.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.10",
          "chgp": "800.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.70",
          "val2": "-0.30",
          "chgp": "-2,800.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "115.80",
          "val2": "58.80",
          "chgp": "96.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "157.90%",
          "val2": "68.80%",
          "chgp": "8.91%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -31.33% vs -40.75% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -159.10% vs -56.85% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,302.20",
          "val2": "3,352.50",
          "chgp": "-31.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-295.10",
          "val2": "639.30",
          "chgp": "-146.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.20",
          "val2": "4.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-41.20",
          "val2": "-31.90",
          "chgp": "-29.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-297.10",
          "val2": "502.70",
          "chgp": "-159.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-128.20%",
          "val2": "135.60%",
          "chgp": "-26.38%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

843.90

663.50

27.19%

Operating Profit (PBDIT) excl Other Income

133.20

90.00

48.00%

Interest

0.90

0.10

800.00%

Exceptional Items

-8.70

-0.30

-2,800.00%

Consolidate Net Profit

115.80

58.80

96.94%

Operating Profit Margin (Excl OI)

157.90%

68.80%

8.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 27.19% vs -56.30% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 96.94% vs -78.25% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,302.20

3,352.50

-31.33%

Operating Profit (PBDIT) excl Other Income

-295.10

639.30

-146.16%

Interest

4.20

4.20

Exceptional Items

-41.20

-31.90

-29.15%

Consolidate Net Profit

-297.10

502.70

-159.10%

Operating Profit Margin (Excl OI)

-128.20%

135.60%

-26.38%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -31.33% vs -40.75% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -159.10% vs -56.85% in Dec 2024

All Annual Results